Bone resorption and formation are dynamic processes that occur in both normal and injured bone tissues. Regulation of these processes is mediated at the local level by cytokines and growth factors. Macrophage migration inhibitory factor (MIF) is one of the proinflammatory cytokines that activates macrophages and regulates production of other cytokines, such as tumour necrosis factor-a and interleukin-1. We here demonstrate, by reverse transcription-polymerase chain reaction, high expression of MIF mRNA in murine osteoblasts obtained from mouse neonatal calvariae and murine osteoblastic MC3T3-E1 cells. The presence of MIF protein in the osteoblasts was confirmed by Western blot analysis using anti-rat MIF antibody. Moreover, the immunohistochemical study revealed that MIF was localized largely in the cytoplasm. The pathophysiological function of MIF remains undefined; however, the present results suggest that MIF takes part in the osseous metabolism as well as in immunological events.
INTRODUCTION
Bone tissue repeats resorption and formation for its remodelling, which is regulated by numerous cytokines, growth factors and hormones. Bone remodelling exhibits a specific phase in which mononuclear cells are recruited. In this phase, macrophages produce the various bioactive substances regulating the bone resorption and formation. [1] [2] [3] [4] [5] [6] [7] [8] [9] In most cases, cytokines, such as tumour necrosis factor-a (TNF-a) and interleukin-1 (IL-1), stimulate bone resorption, whereas growth factors, e.g. transforming growth factor-b (TGF-b), and platelet-derived growth factor (PDGF), stimulate bone formation. In the bone metabolism, macrophages are considered to play an important role. Infiltration of macrophages are observed within the callus in fracture repair throughout the whole process of bone remodelling. 10, 11 This finding strongly suggests that the recruited macrophages are deeply involved in the bone resorption and formation; however, the precise pathophysiological functions of mononuclear cells in the normal or pathological state of bones remain undefined.
The recruitment of macrophages from the peripheral vasculature is induced by chemoattractants released by infiltrating mononuclear cells. In the process of recruitment, macrophage migration inhibitory factor (MIF) was the first lymphokine reported to prevent the random migration of macrophages out of capillary tubes. 12 The protein was considered to be expressed exclusively in activated T lymphocytes; however, a recent report indicated that macrophages are another source of the protein. 13 Human MIF cDNA was the first one cloned, and it was found that MIF consists of 114 amino acid residues.
14 Recently, we cloned rat MIF cDNA, and reported its physiochemical properties. [15] [16] [17] Moreover, we succeeded in the crystallization of both human and rat MIF, and revealed the tertiary structure of rat MIF at 2 . 2 Å resolution. [18] [19] [20] We here report for the first time, by means of reverse transcription-polymerase chain reaction (RT-PCR), Western blot analysis and immunohistochemistry, that MIF is expressed and present in murine osteoblasts. The precise pathophysiological function of MIF remains undetermined; however, the present results suggest the possibility that MIF produced by osteoblasts is profoundly involved in regulation of the bone metabolism.
MATERIALS AND METHODS

Materials
The following materials were obtained from commercial sources. Nitrocellulose membrane filters were purchased from Millipore (Bedford, MA); Isogen RNA extraction kit from Nippon Gene (Tokyo, Japan); M-MLV reverse transcriptase and dispase from Gibco (Grand Island, NY); Taq DNA polymerase from PerkinElmer (Norwalk, CO); Tissue-Tek OCT compound from Miles Scientific (Naperville, IL); horseradish peroxidase (HRP)-conjugated goat anti-rabbit antibody and Micro BCA protein assay kit from Pierce (Rockford, IL); 4-chloro-1-naphthol substrate for HRP from Promega (Madison, WI); Konica immunostaining HRP-1000 from Konica (Tokyo, Japan); complete Freund's adjuvant (CFA), incomplete Freund's adjuvant (IFA), 3,3'-diaminobenzidine tetrahydrochloride from Wako (Osaka, Japan); alkylacrylates from Merck (Darmstadt, Germany); Histofine SAB-PO kit from Nichirei (Tokyo, Japan), and Protein A Sepharose from Pharmacia (Uppsala, Sweden). All other chemicals used were of analytical grade.
Antisera
Polyclonal anti-rat MIF serum was generated by immunizing New Zealand White rabbits by recombinant rat MIF as described. 20, 21 Recombinant rat MIF was expressed in Escherichia coli and purified to homogeneity as previously described. 16 The immunoglobulin G (IgG) fraction (4 mg/ml) was prepared using Protein A Sepharose according to the manufacturer's protocol. Since only a single amino acid residue is different between rat and mouse MIFs, 15 the anti-rat MIF immunologically cross-reacted with mouse MIF.
Osteoblasts
Murine primary osteoblasts were obtained from 1 to 2-day-old ICR murine calvariae. 22 In brief, 30-40 calvariae were stirred for 20 min in 10 ml of a -modified Eagle's medium (a-MEM) containing 0 . 1% collagenase and 20 000 units of dispase. The dispersed cells were collected by centrifugation at 100 g for 10 min. The extraction was repeated five times, and these cells were combined and washed with a -MEM. The collected cells were further cultured in a -MEM containing 10% fetal calf serum, and the medium was changed every 3 days. The cells were harvested at days 6 and 12 by phosphate-buffered saline (PBS) containing 0 . 2% trypsin and 0 . 02% ethylene diamine tetra-acetic acid (EDTA), and stored at 7 808 until use. The purity of osteoblasts was found to be more than 95% by examination using alkaline phosphatase staining.
Cell culture
Murine osteoblastic MC3T3-E1 cells were generously provided by Dr H. Dohi of Ohu University Dental School (Fukushima, Japan). The cells were cultured at 378 in a CO 2 incubator in plastic dishes containing a -MEM supplemented with 10% fetal bovine serum (FBS), and subcultured every 3 days. The cells (3610 4 cells) were cultured for the designated times in 35-mm plastic dishes containing 2 ml a -MEM with 10% FBS. For experiments, cultured cells were rinsed with PBS and the medium was exchanged for medium containing 0 . 1% bovine serum albumin (BSA).
RT-PCR
The total RNAs were extracted from the primary calvaria osteoblasts and MC3T3-E1 cells with an Isogen RNA extraction kit. The reverse transcription of the total RNA was carried out by M-MLV reverse transcriptase using oligo-dT primers followed by amplification using Taq DNA polymerase. PCR was carried out for 25 cycles of denaturation at 948 for 1 min, annealing at 538 for 2 min and extension at 728 for 1 min using a thermal cycler (PerkinElmer, Model 2400). Murine MIF primers used were 5'-TCCGTGCCAGAGGGGTTTCTC-3' (forward) and 5'-AGAACCGCAACTACAGTAAGC-3' 215-235 (reverse). b -Actin primers used were 5'-ATGGATGACGATATCGCTG-3' 1-20 (forward) and 5'-ATGAGGTAGTCTGTCAGGT-3' 551-570 (reverse). After PCR, the amplified products were analysed by agarose gel electrophoresis.
Western blot analysis
The osteoblasts obtained from murine calvariae and MC3T3-E1 osteoblastic cells were disrupted with a Polytrone homogenizer (Kinematica), and the homogenates were dissolved in 20 m l of Tris-HCl 50 mM, pH6 . 8 containing 2-mercaptoethanol (1%), sodium dodecyl sulfate (SDS) (2%), glycerol (20%) and bromophenol blue (BPB) (0 . 04%), and heated at 1008 for 5 min. The samples were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) as described. 23 The proteins on the gel were electrophoretically transferred onto a nitrocellulose membrane at 50 mA for 1 hr using a semi-dry blot transfer apparatus (Bio-Rad). The nitrocellulose membrane was intensively washed with PBS, and incubated with anti-rat MIF polyclonal antibody (1:1000 in dilution) at room temperature for 1 hr, and further reacted with peroxidase-conjugated anti-rabbit IgG serum (1:1000 in dilution) at room temperature for 1 hr. After the reaction, proteins were visualized with a Konica immunostaining MRP-1000 kit as recommended in the manufacturer's protocol. Protein concentration was determined with a Micro BCA protein assay reagent kit.
Immunohistochemistry
Murine calvariae were embedded and frozen in Tissue-Tek OCT compound, and kept at 7 808 until use. Six-micrometre thick cryostat sections were fixed in acetone and treated with 10% normal goat serum for 20 min. After washing three times with PBS for 5 min, the tissues were further incubated with 0 . 3% H 2 O 2 for 20 min at room temperature to block the endogenous peroxidase. On the other hand, osteoblasts from the murine calvariae and MC3T3-E1 cells were placed on a glass slide, fixed in 4% paraformaldehyde in PBS at 48 for 10 min, and dehydrated in ethanol for 5 min. The cell samples were immersed in 0 . 3% H 2 O 2 in methanol for 30 min to quench the endogenous peroxidase. For detecting MIF, the calvaria and osteoblast samples were incubated overnight at 48 with anti-rat MIF polyclonal antibody. The samples were stained with an avidin-biotinperoxidase complex procedure using a Histofine SAB-PO kit according to the manufacturer's protocol. The samples were also counterstained with Meyer's haematoxylin. Non-specific staining was blocked by incubation with normal goat serum (10%) for 10 min.
Enzyme-linked immunosorbent assay (ELISA)
The MIF antibody dissolved in 50 m l of PBS was added to each well of a 96-well microtitre plate, which was then left for 1 hr at room temperature. The plate was washed three times with PBS. All wells were filled with PBS containing 1% BSA for blocking and left for 1 hr at room temperature. After removal of the blocking solution, samples were added in duplicate to individual wells and incubated for 1 hr at room temperature. Next the plate was washed three times with PBS containing Tween 20 (0 . 05%) (washing buffer) and 50 m l of biotin-conjugated MIF antibody. Following incubation for 1 hr at room temperature, the plate was again washed three times with the washing buffer. Then avidin-conjugated goat anti-rabbit IgG antibody was added to individual wells and incubated for 1 hr at room temperature. After the plate was washed three times, 50 m l of a substrate solution containing 200 m g of o-phenylethylenediamine and 10 m l of 30% hydrogen peroxide in 10 m l of citratephosphate buffer (pH 5 . 0) was added to each well. After incubation for 20 min at room temperature, the reaction was stopped with 50 m l of 1 N sulfuric acid. The absorbance at 492 nm was measured using an ELISA plate reader (Bio-Rad, Model 3550).
RESULTS
Expression of MIF mRNA
MIF mRNA expression in the primary murine neonatal calvaria osteoblasts and MC3T3-E1 cells was examined by RT-PCR analysis. Two micrograms of the total RNA was subjected to reverse transcription. From the cDNA library, the specific transcript for mouse MIF was amplified by PCR. At the expected molecular size (196 bp), MIF mRNA products were detected on the agarose gel (Fig. 1) . The relative intensities of the bands normalized by b -actin PCR products did not show any appreciable difference between the primary osteoblasts and MC3T3-E1 cells. No detectable amount of amplified transcript of MIF was observed on murine polymorphonuclear cells (PMN) in the RT-PCR analysis (data not shown). This result indicated that MIF mRNA was constitutively expressed in the osteoblasts.
Western blot analysis
To further confirm the expression of MIF protein by the primary calvaria osteoblasts and MC3T3-E1 cells, Western blot analysis was carried out. The transferred protein bands visualized by a Konica immunostaining HRP-1000 kit migrated to the corresponding molecular mass of MIF, about 12 . 5 kDa (Fig. 2) . In contrast, cell lysates obtained from purified PMN exhibited no detectable amount of MIF protein (data not shown) as previously reported. 13 This result indicated that MIF was produced by both the primary osteoblasts and MC3T3-E1 cells as demonstrated by mRNA expression, and that MIF was synthesized de novo in the murine osteoblasts.
Immunohistochemistry
Immunohistochemical analysis of the neonatal murine calvaria clearly showed the presence of MIF in osteoblasts (Fig. 3a) . This appeared as mononuclear cell sheets on the outer surface of the cartilage tissue as described. 24 The cell type was confirmed by alkaline phosphatase staining of serial sections, which showed a strong positive reaction for these cells (Fig. 3b) . No positive staining was observed in the calvaria in the reaction with preimmune rabbit IgG (Fig. 3c) or with the addition of an excess amount of MIF in this staining procedure (data not shown). Furthermore, we carried out immunohistochemical study for the primary osteoblasts obtained from the calvariae and MC3T3-E1 cells. Positive MIF staining was observed within the cytoplasm of osteoblasts (Figs 4a and 5a ). This staining procedure did not result in any specific staining in the reaction with pre-immune rabbit IgG (Figs 4b and 5b) or with the addition of an excess amount of MIF in this staining procedure (data not shown). Considering these results together, we concluded that MIF produced by murine osteoblasts was localized in the cytoplasm.
Contents of MIF in the culture medium
MIF concentrations in the culture media of the primary culture osteoblasts and MC3T3-E1 cells at 24 hr were measured by ELISA. It showed that a substantial amount of MIF existed in the media of the primary culture osteoblasts and MC3T3-E1 cells, 6 . 8 6 0 . 8 and 3 . 5 6 0 . 5 ng/ml in 5610 4 cells/ml, respectively. This indicated that MIF was not only present in the cytoplasm, but also that part of the MIF was secreted into the extracellular space.
DISCUSSION
In this study, we demonstrated for the first time that MIF mRNA was expressed in murine osteoblasts by RT-PCR. The presence of MIF protein in the osteoblasts was further confirmed by Western blot analysis and immunohistochemistry. To date, it has been reported that MIF stimulates macrophages to secrete other proinflammatory cytokines, e.g. IL-1b, TNF-a, 25, 26 and that these cytokines are profoundly involved in the bone metabolism. 27 This fact indicates that MIF secreted by osteoblasts may regulate the bone resorption and formation as a novel member of the regulatory cytokines. However, the precise pathophysiological function of MIF in the bone metabolism still remains unclear.
To date, MIF is known to be present in highly proliferative tissues, such as the early embryonal chicken lens 28 and the basal cell layers of human skin epidermis and corneal epithelium 21, 29 From these findings, it is considered that MIF might be profoundly associated with cell proliferation and differentiation. That is, MIF may have a function to stimulate cell proliferation and proliferation required for bone remodelling. The major growth factors synthesized by the osteoblasts include insulin-like growth factor, TGF-b, and PDGF, [30] [31] [32] which induce the subsequent stage of the remodelling cycle. 33 Since we found that MIF mRNA was upregulated by PDGF (unpublished observation), it is very likely that MIF may stimulate cellular proliferation in concert with growth factors.
In contrast, osteoclasts resorb minerals and matrices during the reversal phase of bone resorption in the sequence of bone remodelling. It is of interest that macrophages have the potential to differentiate into osteoclasts when the cells are cocultured with stromal cells. 9 Thus, accumulation of macrophages and osteoblasts around the diseased regions is considered to be important in the pathophysiology of chronic destructive bone diseases, e.g. osteoporosis and rheumatoid arthritis. Taken together, the present results suggest that MIF secreted by osteoblasts may also take part in the pathogenesis of these destructive diseases through direct or indirect osteoclast stimulation.
At the sites of bone injury and bone remodelling, significant mononuclear cell recruitment occurs. For example, macrophages and osteoblasts are abundant at early stages of fracture healing, and continue to be present through the later stages of healing. These cells secrete a variety of cytokines and growth factors which are essential for bone repair during the initial stage of healing. 34 Despite the importance of macrophages and osteoblasts in the osseous metabolism, little is known about the regulatory mechanism of macrophage recruitment. From the data available to date, it appears that monocyte chemoattractant protein-1 (MCP-1) may contribute, in part, to the recruitment. 35 The interaction between MIF and MCP-1 has not been described; however, identification of MIF in osteoblasts may illustrate a new aspect of the mechanism of macrophage recruitment in fractured bone tissues.
Recently, MIF was found to act to override glucocorticoidmediated inhibition of inflammatory cytokine production by lipopolysaccharide-stimulated macrophages. 36 This indicates that MIF is a critical component of the immunological and endocrinological systems, and that it acts together with glucocorticoids to regulate immunity and inflammation. Glucocorticoids are known to have profound effects on the proliferation and function of osteoblasts, observed as the reduction of alkaline phosphatase activity, type I collagen and osteocalcin production. [37] [38] [39] That is, MIF may act in an autocrine mode on osteoblasts to alter their functions induced by glucocorticoids. Hence, MIF is considered to be a vital component in various osseous pathophysiological conditions. Further investigation of this topic is currently under way.
